Показано 0 из 0
Дата |
---|
16.05.2024 |
15.05.2024 |
14.05.2024 |
13.05.2024 |
10.05.2024 |
09.05.2024 |
08.05.2024 |
07.05.2024 |
06.05.2024 |
03.05.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
4.75
|
4.88
|
4.68
|
4.68
|
4.95
|
4.75
|
|
|
1 484 997.73
|
2 179.00
|
4.47
|
4.78
|
4.41
|
4.41
|
4.84
|
4.62
|
|
|
1 905 203.72
|
3 368.00
|
4.30
|
4.53
|
4.40
|
4.3053
|
4.56
|
4.38
|
|
|
1 439 840.00
|
4 457.00
|
4.22
|
4.48
|
4.56
|
4.24
|
4.59
|
4.24
|
|
|
1 489 787.06
|
3 175.00
|
4.43
|
4.68
|
4.60
|
4.36
|
4.7277
|
4.44
|
|
|
1 667 572.77
|
3 865.00
|
4.50
|
4.59
|
4.44
|
4.33
|
4.595
|
4.57
|
|
|
1 790 243.47
|
2 931.00
|
4.26
|
4.52
|
4.23
|
4.04
|
4.44
|
4.44
|
|
|
1 348 870.95
|
2 817.00
|
4.17
|
4.38
|
4.27
|
4.1626
|
4.40
|
4.33
|
|
|
1 244 660.50
|
2 413.00
|
4.29
|
4.35
|
4.38
|
4.16
|
4.56
|
4.28
|
|
|
2 387 624.47
|
4 204.00
|
4.33
|
4.56
|
4.62
|
4.25
|
4.76
|
4.32
|
|
|
3 429 533.50
|
3 865.00
|
Sagimet Biosciences Inc. operates as a clinical-stage biopharmaceutical company. The Company develops novel therapeutics called fatty acid synthase (FASN) inhibitors to treat important diseases such as non-alcoholic steatohepatitis (NASH), acne and various cancers. Sagimet Biosciences serves customers worldwide.